In HCC, SNORD17 conferred a higher capacity for proliferation, resistance to apoptosis, and cell cycle progression in vitro, as well as a metastatic capacity of lungs in vivo against cancers [28]. This evidence concerns the gene SNORD17 and hepatocellular carcinoma.